Literature DB >> 20803545

FGF2 promotes Msx2 stimulated PC-1 expression via Frs2/MAPK signaling.

Yan Li1, Jin Liu, Mark Hudson, Sungsu Kim, Nan E Hatch.   

Abstract

PC-1 is an enzymatic generator of pyrophosphate and a critical regulator of tissue mineralization. We previously showed that fibroblast growth factor-2 (FGF2) specifically induces PC-1 expression in calvarial pre-osteoblasts and that this occurs via a transcriptional mechanism involving Runx2. Because aberrant FGF signaling and Msx2 activity result in similar craniofacial skeletal defects and because Msx2 is an established regulator of osteoblastic gene expression, here we investigate Msx2 as an additional mediator of PC-1 gene expression. mRNA analysis and experiments utilizing PC-1 gene promoter/luciferase reporter constructs demonstrate that Msx2 promotes transcription of the PC-1 gene downstream of FGF2. Results indicate that both Msx2 and Runx2 are recruited to a conserved core Msx2 binding site within the PC-1 gene promoter upon FGF2 stimulation, and that Msx2 and Runx2 function together to induce PC-1 gene expression in osteoblastic cells. Here we show that FGF signaling promotes Msx2 transcriptional activity on the PC-1 gene promoter via the Frs2/MAPK signaling pathway. To our knowledge, this is the first report of Msx2 functioning as a transcriptional enhancer downstream of FGF2 in calvarial pre-osteoblasts. As activating mutations in FGF receptors and Msx2 result in similar craniofacial skeletal disorders, our findings support the idea that FGF signaling and Msx2 activity influence cranial osteogenesis via the same molecular mechanism.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20803545     DOI: 10.1002/jcb.22861

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation.

Authors:  Hwa Kyung Nam; Jin Liu; Yan Li; Andrew Kragor; Nan E Hatch
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  The homeobox transcription factor MSX2 partially mediates the effects of bone morphogenetic protein 4 (BMP4) on somatic cell reprogramming.

Authors:  Lilong Lin; Lining Liang; Xiao Yang; Hao Sun; Yuan Li; Duanqing Pei; Hui Zheng
Journal:  J Biol Chem       Date:  2018-08-10       Impact factor: 5.157

3.  MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling.

Authors:  Qingqing Wu; Leisheng Zhang; Pei Su; Xiaohua Lei; Xin Liu; Hongtao Wang; Lisha Lu; Yang Bai; Tao Xiong; Dong Li; Zhengmao Zhu; Enkui Duan; Erlie Jiang; Sizhou Feng; Mingzhe Han; Yuanfu Xu; Fei Wang; Jiaxi Zhou
Journal:  Cell Res       Date:  2015-10-02       Impact factor: 25.617

4.  MSX2 represses tumor stem cell phenotypes within oral squamous cell carcinomas via SOX2 degradation.

Authors:  Reziwan Keyimu; Maimaitituxun Tuerdi; Zhihe Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2021-08-26

5.  The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.

Authors:  Yuan Yin; Chuan-Ming Xie; Hua Li; Mingjia Tan; Guoan Chen; Rachel Schiff; Xiufang Xiong; Yi Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

6.  MSX2 inhibits the growth and migration of osteosarcoma cells by repressing SOX2.

Authors:  Yue Wu; Yi Jin; Norio Yamamoto; Akihiko Takeuchi; Shinji Miwa; Hiroyuki Tsuchiya; Zhijun Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

7.  Systematic analysis of copy number variants of a large cohort of orofacial cleft patients identifies candidate genes for orofacial clefts.

Authors:  Federica Conte; Martin Oti; Jill Dixon; Carine E L Carels; Michele Rubini; Huiqing Zhou
Journal:  Hum Genet       Date:  2015-11-11       Impact factor: 4.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.